Par en January 2020
We invent novel chemistries for protein chemical synthesis and protein modification.
These methodologies are a strong asset for studying the role of proteins involved in human diseases, and for discovering novel protein therapeutic strategies. In the past, we were deeply involved in the study of hepatocyte growth factor (HGF)/MET tyrosine kinase receptor signaling and the design of HGF agonists for regenerative medicine.
Now we focus our research in biology on the development of novel therapeutic strategies against Schistosomiasis through integrated chemical biology programs.